Small Molecule Kinase Inhibitors

Small Molecule Kinase Inhibitors

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Small Molecule Kinase Inhibitors Market to Reach $189.2 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Small Molecule Kinase Inhibitors estimated at US$83.4 Billion in the year 2022, is projected to reach a revised size of US$189.2 Billion by 2030, growing at a CAGR of 10.8% over the period 2022-2030.

The U.S. Market is Estimated at $22.7 Billion, While China is Forecast to Grow at 14.9% CAGR
The Small Molecule Kinase Inhibitors market in the U.S. is estimated at US$22.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$42.6 Billion by the year 2030 trailing a CAGR of 14.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.8% and 8.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.

Select Competitors (Total 83 Featured) -
  • A-Laskuvarjo
  • Aries S.A.
  • ATECH Inc.
  • Bney Meir Ltd.
  • Curtiss-Wright Corporation
  • ESCRIBANO Mechanical and Engineering
  • General Atomics
  • QinetiQ North America
  • Scama AB
  • Wire Rope Industries
  • Wireco WorldGroup
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Small Molecule Kinase Inhibitors – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 2: World Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 3: World 16-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
TABLE 4: World Small Molecule Kinase Inhibitors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
TABLE 5: USA Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 6: USA Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
CANADA
TABLE 7: Canada Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 8: Canada Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
JAPAN
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
TABLE 9: Japan Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 10: Japan Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
CHINA
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
TABLE 11: China Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 12: China Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
EUROPE
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
TABLE 13: Europe Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 14: Europe Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 15: Europe 16-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
FRANCE
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
TABLE 16: France Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 17: France Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
GERMANY
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
TABLE 18: Germany Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 19: Germany Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
ITALY
TABLE 20: Italy Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 21: Italy Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
UNITED KINGDOM
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
TABLE 22: UK Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 23: UK Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
SPAIN
TABLE 24: Spain Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 25: Spain Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
RUSSIA
TABLE 26: Russia Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 27: Russia Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
REST OF EUROPE
TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 29: Rest of Europe Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
ASIA-PACIFIC
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 31: Asia-Pacific Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 32: Asia-Pacific 16-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
AUSTRALIA
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
TABLE 33: Australia Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 34: Australia Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
INDIA
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
TABLE 35: India Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 36: India Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
SOUTH KOREA
TABLE 37: South Korea Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 38: South Korea Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
REST OF ASIA-PACIFIC
TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 40: Rest of Asia-Pacific Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
LATIN AMERICA
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
TABLE 41: Latin America Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 42: Latin America Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 43: Latin America 16-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
ARGENTINA
TABLE 44: Argentina Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 45: Argentina Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
BRAZIL
TABLE 46: Brazil Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 47: Brazil Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
MEXICO
TABLE 48: Mexico Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 49: Mexico Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
REST OF LATIN AMERICA
TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 51: Rest of Latin America Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
MIDDLE EAST
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
TABLE 52: Middle East Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 53: Middle East Historic Review for Small Molecule Kinase Inhibitors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 54: Middle East 16-Year Perspective for Small Molecule Kinase Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
IRAN
TABLE 55: Iran Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 56: Iran Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
ISRAEL
TABLE 57: Israel Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 58: Israel Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
SAUDI ARABIA
TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 60: Saudi Arabia Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
UNITED ARAB EMIRATES
TABLE 61: UAE Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 62: UAE Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
REST OF MIDDLE EAST
TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 64: Rest of Middle East Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
AFRICA
Small Molecule Kinase Inhibitors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
TABLE 65: Africa Recent Past, Current & Future Analysis for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 66: Africa Historic Review for Small Molecule Kinase Inhibitors by Segment - Small Molecule Kinase Inhibitors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings